Purchases and Sales Made in Q1 2023 in Actinium Pharmaceuticals, Inc. (ATNM)
This table provides information about the institutional ownership of Actinium Pharmaceuticals, Inc. (ATNM) during Q1 2023. The information is specifically focused on institutions that hold shares of Actinium Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 01, 2023
Q1 2023
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-5.2K- 19.38% |
$44.3K - $74.2K
|
21.7K
$24.2K
|
|
May 03, 2023
Q1 2023
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-10.6K- 44.79% |
$90.4K - $151K
|
13.1K
$14.7K
|
|
May 15, 2023
Q1 2023
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-25K- 28.1% |
$213K - $357K
|
64K
$71.6K
|
|
May 15, 2023
Q1 2023
|
J. Goldman & CO LP
New York, NY |
SELL
|
- |
-37.9K- 47.29% |
$322K - $540K
|
42.2K
$47.3K
|
|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-52.5K- 43.23% |
$447K - $748K
|
68.9K
$77.2K
|
|
May 12, 2023
Q1 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-57.4K- 35.96% |
$488K - $819K
|
102K
$114K
|
|
May 15, 2023
Q1 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-105K- 44.04% |
$897K - $1.5M
|
134K
$150K
|
|
May 15, 2023
Q1 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-168K- 78.65% |
$1.43M - $2.39M
|
45.5K
$51K
|
|
May 15, 2023
Q1 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-236K- 85.24% |
$2.01M - $3.37M
|
40.9K
$45.8K
|